Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajiv S Jumani

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Bio-Protocol|July 15, 2024
Imaging Assays to Detect DNA Damage in Trypanosome Parasites Using γH2ARajiv S Jumani, Bryanna Thomas, Srinivasa P S Rao
Plos Pathogens|June 20, 2014
The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCGVijaya Satchidanandam, Naveen Kumar, Rajiv S Jumani, et al.
ACS Infectious Diseases|October 16, 2019
Innovations in Addressing Pediatric Diarrhea in Low Resource SettingsRajiv S Jumani, Jonathan M Spector, Rasa Izadnegahdar, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria boxKovi Bessoff, Thomas Spangenberg, Jenna E Foderaro, et al.
Clinical and Vaccine Immunology : CVI|February 5, 2016
The Secreted Protein Rv1860 of Mycobacterium tuberculosis Stimulates Human Polyfunctional CD8+ T CellsVijaya Satchidanandam, Naveen Kumar, Sunetra Biswas, et al.
Plos Neglected Tropical Diseases|January 9, 2018
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis modelErin Stebbins, Rajiv S Jumani, Connor Klopfer, et al.
Plos Neglected Tropical Diseases|February 4, 2017
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosisMelissa S Love, Federico C Beasley, Rajiv S Jumani, et al.
Bioorganic & Medicinal Chemistry|February 7, 2017
Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitorKhan T Osman, Juntao Ye, Zhihao Shi, et al.
Nature Communications|April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitorsRajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Plos Pathogens|April 26, 2024
Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiationMuhammad M Hasan, Ethan B Mattice, José E Teixeira, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Bio-Protocol|July 15, 2024
Imaging Assays to Detect DNA Damage in Trypanosome Parasites Using γH2ARajiv S Jumani, Bryanna Thomas, Srinivasa P S Rao
Plos Pathogens|June 20, 2014
The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCGVijaya Satchidanandam, Naveen Kumar, Rajiv S Jumani, et al.
ACS Infectious Diseases|October 16, 2019
Innovations in Addressing Pediatric Diarrhea in Low Resource SettingsRajiv S Jumani, Jonathan M Spector, Rasa Izadnegahdar, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria boxKovi Bessoff, Thomas Spangenberg, Jenna E Foderaro, et al.
Clinical and Vaccine Immunology : CVI|February 5, 2016
The Secreted Protein Rv1860 of Mycobacterium tuberculosis Stimulates Human Polyfunctional CD8+ T CellsVijaya Satchidanandam, Naveen Kumar, Sunetra Biswas, et al.
Plos Neglected Tropical Diseases|January 9, 2018
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis modelErin Stebbins, Rajiv S Jumani, Connor Klopfer, et al.
Plos Neglected Tropical Diseases|February 4, 2017
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosisMelissa S Love, Federico C Beasley, Rajiv S Jumani, et al.
Bioorganic & Medicinal Chemistry|February 7, 2017
Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitorKhan T Osman, Juntao Ye, Zhihao Shi, et al.
Nature Communications|April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitorsRajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Plos Pathogens|April 26, 2024
Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiationMuhammad M Hasan, Ethan B Mattice, José E Teixeira, et al.
Pageof 3